Quest PharmaTech (TSXV:QPT) Net Issuance of Preferred Stock : C$0.00 Mil (TTM As of Oct. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Quest PharmaTech's net issuance of preferred for the three months ended in Oct. 2023 was C$0.00 Mil. The number is 0, which means that Quest PharmaTech has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Quest PharmaTech's net issuance of preferred for the trailing twelve months (TTM) ended in Oct. 2023 was C$0.00 Mil.

Quest PharmaTech Net Issuance of Preferred Stock Historical Data

The historical data trend for Quest PharmaTech's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest PharmaTech Net Issuance of Preferred Stock Chart

Quest PharmaTech Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Quest PharmaTech Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Quest PharmaTech Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Quest PharmaTech Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Quest PharmaTech's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest PharmaTech (TSXV:QPT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4

Website

http://www.questpharmatech.com

Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.

Executives

Ragupathy Madiyalakan

Director

Quest PharmaTech (TSXV:QPT) Headlines

No Headlines